Disparate unloading efficacy of the calcium channel blockers, verapamil and nifedipine, on the failing hypertensive left ventricle
- PMID: 6375329
- DOI: 10.1016/0002-8703(84)90553-2
Disparate unloading efficacy of the calcium channel blockers, verapamil and nifedipine, on the failing hypertensive left ventricle
Abstract
Calcium channel blockers reduce arterial smooth muscle tone and lower blood pressure. They may be regarded as left ventricular (LV) unloading agents. LV unloading efficacy of nifedipine (15 patients) and verapamil (14 patients) was tested in hypertensive decompensated patients, during a 1-month treatment period. Nifedipine persistently reduced systemic vascular resistance (SVR), mean arterial pressure, mean pulmonary wedge pressure (PWP), and LV diastolic diameter, and improved cardiac index and velocity of circumferential fiber shortening (Vcf). All of the patients had relief from dyspnea and reduction in heart size. The only side effect was ankle edema in six. Verapamil reduced SVR and mean arterial pressure and was not effective on PWP, LV diastolic diameter, and Vcf. The drug was discontinued in two patients who developed severe dyspnea at rest after 3 to 4 days of continuous oral treatment. Clinical symptoms and signs did not improve in the remaining patients despite persistent pressure reduction. A less potent vasodilating action of verapamil and a prominent depression in cardiac contractility may account for the differential results with the two compounds, in spite of a shared vasodilating antihypertensive effect. These findings indicate that functional changes in the failing hypertensive heart may differ from one calcium blocker to another as a result of interaction and relative preponderance of influence on afterload and contractility.
Similar articles
-
Clinical use of calcium channel blockers as ventricular unloading agents.Eur Heart J. 1983 Jan;4 Suppl A:181-7. doi: 10.1093/eurheartj/4.suppl_a.181. Eur Heart J. 1983. PMID: 6220895 Clinical Trial.
-
Left ventricular unloading with calcium antagonists.G Ital Cardiol. 1984 Sep;14(9):694-8. G Ital Cardiol. 1984. PMID: 6239802
-
Sublingual nifedipine: acute effects in severe chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy.Am J Cardiol. 1985 May 1;55(11):1359-62. doi: 10.1016/0002-9149(85)90504-1. Am J Cardiol. 1985. PMID: 3993570
-
Calcium-channel blocking agents.Clin Pharm. 1982 Jan-Feb;1(1):17-33. Clin Pharm. 1982. PMID: 6764159 Review.
-
[Role of calcium antagonists in the pharmacologic treatment of heart insufficiency].Rev Port Cardiol. 1989 Jul-Aug;8(7-8):547-52. Rev Port Cardiol. 1989. PMID: 2698718 Review. Portuguese.
Cited by
-
Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications.Cardiovasc Drugs Ther. 1988 Mar;1(6):625-56. doi: 10.1007/BF02125750. Cardiovasc Drugs Ther. 1988. PMID: 3154329 Review.
-
The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review.Drugs. 1986 Jul;32(1):66-101. doi: 10.2165/00003495-198632010-00004. Drugs. 1986. PMID: 2874975 Review.
-
Afterload reduction: a comparison of captopril and nifedipine in dilated cardiomyopathy.Br Heart J. 1986 Apr;55(4):391-9. doi: 10.1136/hrt.55.4.391. Br Heart J. 1986. PMID: 3516187 Free PMC article. Clinical Trial.
-
Calcium antagonists and chronic cardiac failure.Postgrad Med J. 1986 Aug;62(730):713-7. doi: 10.1136/pgmj.62.730.713. Postgrad Med J. 1986. PMID: 3534840 Free PMC article. Review. No abstract available.
-
Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.Drugs. 1985 Sep;30(3):182-274. doi: 10.2165/00003495-198530030-00002. Drugs. 1985. PMID: 2412780 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical